<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1699-714X</journal-id>
<journal-title><![CDATA[Revista de la OFIL ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. OFIL·ILAPHAR]]></abbrev-journal-title>
<issn>1699-714X</issn>
<publisher>
<publisher-name><![CDATA[Organización de Farmacéuticos Ibero-Latinoamericanos]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1699-714X2021000400004</article-id>
<article-id pub-id-type="doi">10.4321/s1699-714x2021000400004</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Impacto en la producción de material contaminante y eficiencia del reetiquetado respecto al reenvasado de medicamentos]]></article-title>
<article-title xml:lang="en"><![CDATA[The environmental impact of relabeling process compared with the unitary dose repackaging]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Salguero-Olid]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rueda-Naharro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez-Camacho]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García-Marco]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Nacional de Parapléjicos de Toledo Servicio de Farmacia Hospitalaria ]]></institution>
<addr-line><![CDATA[Toledo ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Nacional de Parapléjicos de Toledo Servicio de Farmacia Hospitalaria ]]></institution>
<addr-line><![CDATA[Toledo ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<volume>31</volume>
<numero>4</numero>
<fpage>347</fpage>
<lpage>351</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1699-714X2021000400004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1699-714X2021000400004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1699-714X2021000400004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo: Analizar el impacto en la producción de material contaminante y la eficiencia del reetiquetado con el programa Dale color a tu dosis unitariarespecto al reenvasado.  Método: Se analizó la cantidad de material empleado en la elaboración de 100.000 dosis unitarias mediante reetiquetado y reenvasado para calcular el ahorro de material obtenido con el proceso de reeetiquetado. Además, se midió el espacio ocupado por el material contaminante generado en ambos procesos y se realizó una estimación de la producción en función de la capacidad del hospital. Se calculó el coste asociado al material empleado en ambos procesos para el acondicionamiento de 100.000 dosis unitarias, así como el de la maquinaria necesaria para reetiquetar y reenvasar durante 20 años.  Resultados: Se generaron 2,11-4,54 kg de plástico en el reetiquetado de 100.000 dosis unitarias (según el formato de etiqueta), y 67,82 kg de material contaminante para la misma cantidad de reenvasados, siendo el reetiquetado 15-32 veces menos contaminante en peso. Además, el reetiquetado supuso un ahorro de 620,64-702,43 m2 de material contaminante (6-13 veces menos contaminante en espacio). Un hospital de tercer nivel que elabore 1-2 millones de reenvasados al año, produciría anualmente hasta 1.356,40 kg de material contaminante. En cuanto a los costes, el reetiquetado supuso un ahorro de material del 89% (1.580 &#8364;), y del 98,2% (17.830 &#8364;) en cuanto a la amortización de la maquinaria durante 20 años.  Conclusiones: El reetiquetado parece ser una alternativa más eficiente y respetuosa con el medio ambiente en materia de generación de residuos contaminantes respecto al reenvasado.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY  Objective: To analyze the environmental impact of relabeling process with &#8220;Color your unitary dose&#8221; program and the efficiency compared to the traditional repackaging.  Method: The contaminating material used in the relabeling and repackaging of 100,000 unitary dose was calculated. In addition, the area occupied by the contaminating material produced in both processes was measured to determinate the saving of material with the relabeling process, and an approximate estimation of material production was made according to the hospital capacity. The cost associated to the material required in both processes and the machinery needed to relabeling and repackaging during 20 years was evaluated.  Results: The contaminating material used in the relabeling of 100,000 unitary dose was 2.11 kg and 4.54 kg of plastic (depending on the label model used), and 67.82 kg (plastic, aluminum and tracing) in the traditional repackaging process. The area occupied by the contaminating material produced in both processes was 56.81 m2 and 138.60 m2 (relabeling), and 759.24 m2 (repackaging), which means a saving of 620.64 m2 and 702.43 m2 of contaminating material (15-32 times less polluting in weight and 6-13 times, in space). A third level hospital that repackages 2 million unitary dose would annually produce around 1,356.40 kg. A saving of 89% (1,580 &#8364;) of material used was obtained with the relabeling, and 98.2% (17,830 &#8364;) in terms of the cost of amortization of the machinery necessary for 20 years.  Conclusions: The relabeling was an efficient and less polluting process than the traditional repackaging system, so we should only use it for medications that can not be relabelled.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Apariencia similar]]></kwd>
<kwd lng="es"><![CDATA[dosis unitaria]]></kwd>
<kwd lng="es"><![CDATA[etiquetado de medicamentos]]></kwd>
<kwd lng="es"><![CDATA[envasado de medicamentos]]></kwd>
<kwd lng="es"><![CDATA[contaminación]]></kwd>
<kwd lng="en"><![CDATA[Similar appearance]]></kwd>
<kwd lng="en"><![CDATA[unit dose]]></kwd>
<kwd lng="en"><![CDATA[drug labeling]]></kwd>
<kwd lng="en"><![CDATA[drug packaging]]></kwd>
<kwd lng="en"><![CDATA[environmental pollution]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giménez-Poderós]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Módulo 1: impacto de los eventos adversos en la atención sanitaria]]></article-title>
<source><![CDATA[Prevención de errores de medicación en farmacia hospitalaria]]></source>
<year>2016</year>
<edition>1a ed</edition>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Sanidad y Ediciones, S.L]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Allué]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Chiarello]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Bernal-Delgado]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Castells]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Giraldo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Assessing the economic impact of adverse events in Spanish hospitals by using administrative data]]></article-title>
<source><![CDATA[Gac Sanit]]></source>
<year>2014</year>
<volume>28</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>48-54</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Marco]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Olmos Jiménez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Implantación y eficiencia del proceso de reetiquetado de dosis unitarias mediante el sistema Dale color a tu dosis unitaria]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Fundación Signo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="journal">
<collab>American Society of Health-System Pharmacist</collab>
<article-title xml:lang=""><![CDATA[ASHP Guidelines on Preventing Medication Errors in Hospitals]]></article-title>
<source><![CDATA[Am J Health-Syst Pharm]]></source>
<year>2018</year>
<volume>75</volume>
<page-range>1493-517</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Keers]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Cooke]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Causes of medication administration errors in hospitals: a systematic review of quantitative and qualitative evidence]]></article-title>
<source><![CDATA[Drug Saf]]></source>
<year>2013</year>
<volume>36</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1045-67</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="book">
<collab>Institute for Safe Medication Practices</collab>
<source><![CDATA[Start the New Year Off Right by Preventing These Top 10 Medication Errors and Hazards]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Horsham ]]></publisher-loc>
<publisher-name><![CDATA[Institute For Safe Medication Practices]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz Fernández]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[García Marco]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Shaw Toda]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluar la aceptación del proyecto Dale color a tu dosis unitaria]]></article-title>
<source><![CDATA[Nure Inv]]></source>
<year>2009</year>
<volume>43</volume>
</nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vázquez Morilla]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sotelo Navarro]]></surname>
<given-names><![CDATA[PX]]></given-names>
</name>
<name>
<surname><![CDATA[Espinosa Valdemar]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Velasco Pérez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Quecholac Piña]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Beltrán Villavicencia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Degradación &amp; Biodegradación de Plásticos]]></source>
<year>2018</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Asociación Nacional de la Industria Química]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[La Belle]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
<name>
<surname><![CDATA[Bouwman]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Neretin]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Marine Debris as a Global Environmental Problem: Introducing a solutions based framework focused on plastic. A STAP (The Scientific and Technical Advisory Panel) Information Document]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Washington ]]></publisher-loc>
<publisher-name><![CDATA[Global Environment Facility]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Desechos de las actividades de atención sanitaria]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="book">
<collab>National Geographic</collab>
<source><![CDATA[¿Es posible proporcionar atención médica sin plástico?]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Washington ]]></publisher-loc>
<publisher-name><![CDATA[National Geographic]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
